Evidence map›Paper›PMID 36467611›Full record

ArticleFrontiers in cellular neuroscience2022

Attenuated iron stress and oxidative stress may participate in anti-seizure and neuroprotective roles of xenon in pentylenetetrazole-induced epileptogenesis.

Mengdi Zhang, Yao Cheng, Yujie Zhai, Yi Yuan, Haoran Hu, Xianfeng Meng, Xuemeng Fan, Hongliu Sun, Shucui Li

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Mengdi ZhangSchool of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China.
Yao ChengSchool of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China.
Yujie ZhaiSchool of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China.
Yi YuanSchool of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China.
Haoran HuSchool of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China.
Xianfeng MengSchool of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China.
Xuemeng FanSchool of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China.
Hongliu SunSchool of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China.
Shucui LiSchool of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China.
Binzhou Medical University · CNBinzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The previous studies have demonstrated the excellent neuroprotective effects of xenon. In this study, we verified the anti-seizure and neuroprotective roles of xenon in epileptogenesis and evaluated the involvement of oxidative stress and iron accumulation in the protective roles of xenon. Epileptogenesis was induced by pentylenetetrazole (PTZ) treatment in Sprague-Dawley rats. During epileptogenesis, we found increased levels of iron and oxidative stress accompanied by elevated levels of divalent metal transporter protein 1 and iron regulatory protein 1, which are closely associated with iron accumulation. Meanwhile, the levels of autophagy and mitophagy increased, alongside significant neuronal damage and cognitive deficits. Xenon treatment reversed these effects: oxidative stress and iron stress were reduced, neuronal injury and seizure severity were attenuated, and learning and memory deficits were improved. Thus, our results confirmed the neuroprotective and anti-seizure effects of xenon treatment in PTZ-induced epileptogenesis. The reduction in oxidative and iron stress may be the main mechanisms underlying xenon treatment. Thus, this study provides a potential intervention strategy for epileptogenesis.

Indexed as

epileptogenesisiron stressneuronal injuryoxidative stressxenon

Identifiers

PMID36467611
PMCPMC9712733
OpenAlexW4309613948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.